Gainers
- Helius Medical Tech HSDT stock rose 47.8% to $1.11 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.1 million.
- Dogwood Therapeutics DWTX shares increased by 36.89% to $2.56. The market value of their outstanding shares is at $3.4 million.
- TNF Pharmaceuticals TNFA shares rose 19.82% to $1.39. The market value of their outstanding shares is at $3.8 million.
- Redhill Biopharma RDHL stock increased by 19.75% to $6.75. The company's market cap stands at $8.6 million.
- Tempus AI TEM shares rose 19.14% to $41.88. The company's market cap stands at $6.5 billion.
- Design Therapeutics DSGN stock rose 17.39% to $5.94. The company's market cap stands at $336.3 million.
Losers
- Baird Medical Investment BDMD shares declined by 14.1% to $7.6 during Tuesday's pre-market session. The market value of their outstanding shares is at $276.3 million.
- AEON Biopharma AEON shares fell 12.47% to $0.13. The market value of their outstanding shares is at $10.7 million.
- Biomerica BMRA stock decreased by 10.94% to $0.57. The company's market cap stands at $10.4 million.
- Akoya Biosciences AKYA stock fell 10.64% to $2.52. The market value of their outstanding shares is at $124.9 million.
- Rapid Micro Biosystems RPID shares fell 9.76% to $1.11. The company's market cap stands at $47.7 million.
- Bio-Rad Laboratories BIO stock decreased by 9.1% to $310.0. The company's market cap stands at $8.8 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AKYAAkoya Biosciences Inc
$2.52-10.6%
BDMDBaird Medical Investment Holdings Ltd
$7.39-16.5%
BIOBio-Rad Laboratories Inc
$342.41-%
BMRABiomerica Inc
$0.5603-12.4%
DSGNDesign Therapeutics Inc
$5.9517.6%
DWTXDogwood Therapeutics Inc
$2.6843.3%
HSDTHelius Medical Technologies Inc
$0.7401-1.45%
RDHLRedhill Biopharma Ltd
$5.813.07%
RPIDRapid Micro Biosystems Inc
$1.11-9.76%
TEMTempus AI Inc
$42.7521.6%
TNFATNF Pharmaceuticals Inc
$1.13-2.59%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in